Calloway Nathaniel
Insider CIK 1952771 · LFCR Director · ANEB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANEB Anebulo Pharmaceuticals, I | A Award deriv | 2025-04-04 | 2025-04-07 | 3,309 | — | $0 | 3,309 | SEC↗ |
| ANEB Anebulo Pharmaceuticals, I | A Award deriv | 2025-04-04 | 2025-04-07 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award | 2024-07-08 | 2024-07-10 | 30,000 | — | $0 | 58,069 | SEC↗ |
| ANEB Anebulo Pharmaceuticals, I | A Award deriv | 2024-06-13 | 2024-06-17 | 41,667 | — | $0 | 41,667 | SEC↗ |
| ANEB Anebulo Pharmaceuticals, I | A Award deriv | 2024-06-13 | 2024-06-17 | 1,655 | — | $0 | 1,655 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | M Exercise deriv | 2024-02-01 | 2024-02-02 | 3,981 | — | $0 | 0 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | M Exercise | 2024-02-01 | 2024-02-02 | 3,981 | — | $0 | 28,069 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | M Exercise deriv | 2024-01-09 | 2024-01-10 | 5,906 | — | $0 | 0 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | M Exercise | 2024-01-09 | 2024-01-10 | 5,906 | — | $0 | 24,088 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award | 2023-06-01 | 2023-06-05 | 18,182 | — | $0 | 18,182 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award deriv | 2023-02-01 | 2023-02-02 | 3,981 | — | $0 | 3,981 | SEC↗ |
| LFCR LIFECORE BIOMEDICAL, INC. | A Award deriv | 2023-01-09 | 2023-01-11 | 5,906 | — | $0 | 5,906 | SEC↗ |
| ANEB Anebulo Pharmaceuticals, I | A Award deriv | 2022-11-01 | 2022-11-02 | 59,149 | — | $0 | 59,149 | SEC↗ |